Evidence map›Paper›PMID 32582152›Full record

ArticleFrontiers in immunology2020

Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.

Yujuan Zhang, Yuanyuan Feng, Yanqing Huang, Yifan Wang, Li Qiu, Yanling Liu, Shanshan Peng, Rong Li, Nanzhen Kuang, Qiaofa Shi and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Multifunctional CuBiSFrontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Yujuan ZhangInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Yuanyuan FengInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Yanqing HuangInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Yifan WangInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Li QiuDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Yanling LiuInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Shanshan PengInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Rong LiInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Nanzhen KuangInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Qiaofa ShiInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Yanmei ShiDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yiguo ChenMedical Laboratory, Jiangxi Provincial People's Hospital, Nanchang, China.
Rakesh JoshiDepartment of Surgery, Pathology and Oncology, University of Western Ontario, London, ON, Canada.
Zhigang WangInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Keng YuanInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Weiping MinInstitute of Immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.
Jiangxi Provincial Academy of Medical Sciences · CNNanchang University · CNGuangxi Maternal and Child Health Hospital · CNJiangxi Provincial People's Hospital · CNPeking University People's Hospital · CNWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoptosisPhotothermal TherapyRNA InterferenceRNAi TherapeuticsAnimalsCarcinoma, Lewis LungCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCombined Modality TherapyFemaleGene Transfer TechniquesGoldIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaLymphocytes, Tumor-InfiltratingMice, Inbred C57BLGoldIFNG protein, mouseIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaRNA, Small InterferingTnf protein, mouseTumor Necrosis Factor-alpha3-dioxygenase)GNR (gold nanorods)IDO (Indoleamine 2LLC (lewis lung cancer)LSPR (localized surface plasmon resonance)PTT (photothermal therapy)

Identifiers

PMID32582152
PMCPMC7295913
OpenAlexW3034296126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.